Document is current
Any future updates will be listed below
-
Authors
Younas, Mariam https://orcid.org/0000-0003-1112-7392
Royer, Julie
Weissman, Sharon B.
Waites, Katie S.
Dash, Sangita
Rac, Hana
Bookstaver, P. Brandon
Justo, Julie Ann
Bell, Linda
Maki, Anton Jr.
Al-Hasan, Majdi N.
-
Funding
Funding for this research was provided by:
Centers for Disease Control and Prevention (Epidemiology, Laboratory Capacity Project K2)
- License Information
-
More Information
Article History
Received: 19 June 2019
Accepted: 16 October 2019
First Online: 1 November 2019
Compliance with ethical standards
:
: All other authors report no potential conflicts of interest.
: PBB served as a research advisory board member of CutisPharma, Synthetic Biologics and on Advisory board and speaker’s bureau of Melinta Therapeutics. He also received a grant from ALK Abello, Inc.
: This study was approved by South Carolina DHEC and the South Carolina Data Oversight Council (DOC). The findings of this report are those of the authors and do not necessarily represent the official position of the South Carolina DHEC, DOC, or the Revenue and Fiscal Affairs Office. The preliminary results of this study were presented in part at IDWeek, October 3–7, 2018 in San Francisco, CA, USA (Abstract # 475). MY and JR have full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the analysis.
